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Abstract 
Oral transmucosal (OTM) delivery is a simple and painless method for sedative administration in 
veterinary medicine and allows a rapid absorption without a first-pass metabolism by the liver (Porters 
et al., 2014.). OTM is particularly useful in aggressive animals (Santos et al., 2010). The aim of this study 
is to evaluate the efficacy of the OTM route in dogs for sedative administration in comparison with 
intramuscular (IM) injection. 24 mixed-breed dogs undergoing soft tissue surgery or diagnostic 
procedures were randomly divided in 4 groups (n = 6): two groups received OTM administration of 
dexmedetomidine (10 µg/kg-1) together with butorphanol (0.2 mg/kg-1, BTF-OTM group) or 
methadone (0.2mg/kg-1, MTD-OTM group); two groups received intramuscular (IM) administration of 
dexmedetomidine (5 µg/kg-1) together with butorphanol (0.2 m/kg-1, BTF-IM group) or methadone 
(0.2 mg/kg-1, MTD-IM). Heart rate (HR), respiratory rate (RR), sedation score (Gruney et al., 2009) and 
side effects were recorded 10 (T10), 20 (T20) and 30 (T30) minutes after premedication. Induction was 
performed at T30 with titrate-to-effect propofol administration and the dosage required was 
recorded. At each time point BTF-IM group showed a statistically lower HR compared to BTF-OTM; RR 
was statistically lower at T10 in MTD-OTM group (21.33 ± 8.64 pm) compared to BTF-OTM (46.16 ± 
17.98); Dogs in group MTD-IM reached a higher sedation scores at each time point compared to MTD-
OTM. The induction dose of propofol appears comparable among groups. Marked vasoconstriction 
was observed after OTM administration, as probably related to α2-agonists use. Emesis and sialorrhea 
occurred in two subjects of MTD-OTM group while only one dog presented sialorrhea in BTF-OTM 
group. In conclusion, OTM administration appears effective and easy to perform; it takes a longer time 
to achieve a good sedation score, probably related to a gradual absorption of drugs that also leads to 
a more gradual hemodynamic effects. 
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